Confirming that SphK1 activation was a consequence of PLD stimulation, butan-1-ol (1-ButOH), a potent inhibitor of PLD activation, markedly inhibited SphK1 activity in all ccRCC cell lines (Figure 2b and Supplementary Figure 1B). This evidence concerns the gene SPHK1 and nonpapillary renal cell carcinoma.